| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.8 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | -0.007 | 0.9 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | -0.0074 | 0.9 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.9 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | -0.0067 | 0.9 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.0068 | 0.9 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0066 | 0.9 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | 0.0093 | 0.9 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.0062 | 0.9 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | -0.0069 | 0.9 |